跳至主要内容
临床试验/CTRI/2024/07/070307
CTRI/2024/07/070307尚未招募3 期

A Randomised Controlled Clinical study to evaluate the efficacy of Dadimadi gutika in themanagement of Primary Hypothyroidism. - NI

R A Podar Govt (Ayu) College,Worli,Mumbai-180 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Signs and symptoms of primary hypothyroidism.
  • 2) Newly diagnosed patient of primary hypothyroidism.
  • 3) Subjects who are willing to give written informed consent.
  • 4) Serum TSH level above 5.5µU/ml but below 20 µU/ml.

排除标准

  • 1)Any complication arising during the treatment or if any patient discontinuing the treatment will be excluded.
  • 2) Patients having active PR bleeding, active haemorrhoid, fissure in ano, fistula in ano etc.
  • 3) Pregnant and lactating mothers
  • 4) Hypertension, Diabetes Mellitus, Hypothyroidism due to excessive radiation therapy in treating cancer like lymphoma.
  • 5) Malignancy of Thyroid Gland
  • 6) Any other metabolic or systemic disease conditions where other treatment is urgent and was disturb the regimen. (HIV, Diabetes Cardiovascular disease, Tuberculosis etc.)
  • 7) Patient having myxoedema coma.
  • 8) Patients having X-Syndrome, Down’s syndrome, Turner’s syndrome, Klinefelter’s Syndrome carpel tunnel syndrome will be excluded.
  • 9) Patient having Hypothyroidism due to Hypothalamic and Pituitary dysfunction.
  • 10) Present history of any mental disorder.
  • 11)Patient with chronic hyper acidity

研究者

发起方
R A Podar Govt (Ayu) College,Worli,Mumbai-18

相似试验